Gillette Children’s conducts clinical research every day to answer some of the most important questions for patients and families. We focus on improving treatments and making life better for children with medical conditions or disabilities.

At the 2021 Annual Meeting of the International Perthes Study Group (IPSG), organizers announced that Gillette is second in the world in its enrollment of Perthes patients into IPSG studies.

A new survey hopes to provide a better understanding of the challenges to health care access for Minnesota families as they care for a child who has a rare disease. One in ten Minnesotans are living with a rare disease. Gillette Children's is known worldwide for its expert level of care for children who have rare diseases and is encouraging participation in the Rare Disease Healthcare Access Study.

There's a new level of excitement and commitment to conducting research at Gillette that could change and improve the lives of countless numbers of children everywhere, and donor support is pivotal in leading the charge. 

A move from Arkansas to Minnesota led to Jacob receiving a surgical procedure that changed his life, making it possible for him to fulfill his dream of running track.